$LEXG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LEXICON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in LEXICON PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 5,807 | 0 | 5,807 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,929 | 0 | 0 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 8.53 | 6,133 | 52,314 | 59,492 | 65.6 K to 59.5 K (-9.35 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,797 | 0 | 65,625 | 62.8 K to 65.6 K (+4.45 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 4,495 | 0 | 62,828 | 58.3 K to 62.8 K (+7.71 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 5,807 | 0 | 58,333 | 52.5 K to 58.3 K (+11.06 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,929 | 0 | 52,526 | 49.6 K to 52.5 K (+5.91 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 8,970 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 8.53 | 728 | 6,210 | 2,262 | 3 K to 2.3 K (-24.35 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 2,990 | 0 to 3 K |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,270 | 0 | 3,810 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,075 | 0 | 4,150 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,668 | 0 | 2,668 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,340 | 0 | 0 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 8.53 | 1,805 | 15,397 | 25,643 | 27.4 K to 25.6 K (-6.58 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,270 | 0 | 27,448 | 26.2 K to 27.4 K (+4.85 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,075 | 0 | 26,178 | 24.1 K to 26.2 K (+8.61 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,668 | 0 | 24,103 | 21.4 K to 24.1 K (+12.45 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,340 | 0 | 21,435 | 20.1 K to 21.4 K (+6.67 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,592 | 0 | 7,778 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,353 | 0 | 4,705 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 8.53 | 1,652 | 14,092 | 4,552 | 6.2 K to 4.6 K (-26.63 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,592 | 0 | 6,204 | 3.6 K to 6.2 K (+71.76 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,353 | 0 | 3,612 | 1.3 K to 3.6 K (+186.89 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 2,497 | 0 | 7,493 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 4,085 | 0 | 8,170 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 5,272 | 0 | 5,271 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | M | 0.00 | 2,679 | 0 | 0 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Payment of Exercise | F | 8.53 | 4,962 | 42,326 | 53,801 | 58.8 K to 53.8 K (-8.44 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 2,497 | 0 | 58,763 | 56.3 K to 58.8 K (+4.44 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 4,085 | 0 | 56,266 | 52.2 K to 56.3 K (+7.83 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 5,272 | 0 | 52,181 | 46.9 K to 52.2 K (+11.24 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Buy | M | 0.00 | 2,679 | 0 | 46,909 | 44.2 K to 46.9 K (+6.06 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,585 | 0 | 7,755 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,228 | 0 | 8,455 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,550 | 0 | 4,550 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,821 | 0 | 0 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 8.53 | 4,822 | 41,132 | 33,975 | 38.8 K to 34 K (-12.43 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,585 | 0 | 38,797 | 36.2 K to 38.8 K (+7.14 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,228 | 0 | 36,212 | 32 K to 36.2 K (+13.22 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,550 | 0 | 31,984 | 27.4 K to 32 K (+16.59 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,821 | 0 | 27,434 | 24.6 K to 27.4 K (+11.46 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 5,362 | 0 | 16,088 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 8,390 | 0 | 16,780 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 10,836 | 0 | 10,835 | |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 8.53 | 9,494 | 80,984 | 58,079 | 67.6 K to 58.1 K (-14.05 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 5,362 | 0 | 67,573 | 62.2 K to 67.6 K (+8.62 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 8,390 | 0 | 62,211 | 53.8 K to 62.2 K (+15.59 %) |
Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 10,836 | 0 | 53,821 | 43 K to 53.8 K (+25.21 %) |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 9.79 | 79,550 | 778,795 | 79,550 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | A | 0.00 | 28,665 | 0 | 28,665 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 9.79 | 82,820 | 810,808 | 82,820 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 0.00 | 29,180 | 0 | 29,180 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 9.79 | 18,970 | 185,716 | 18,970 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 12,640 | 0 | 12,640 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 9.79 | 71,940 | 704,293 | 71,940 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | A | 0.00 | 25,390 | 0 | 25,390 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | A | 9.79 | 69,940 | 684,713 | 69,940 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Commercial Sup ... | Option Exercise | A | 0.00 | 24,890 | 0 | 24,890 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 9.79 | 72,330 | 708,111 | 72,330 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | A | 0.00 | 25,710 | 0 | 25,710 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 9.79 | 211,610 | 2,071,662 | 211,610 | |
Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | A | 0.00 | 70,540 | 0 | 70,540 | |
Nov 17 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.85 | 50,000 | 492,500 | 1,550,000 | 1.5 M to 1.6 M (+3.33 %) |
Nov 17 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 10.21 | 130,727 | 1,334,396 | 1,500,000 | 1.4 M to 1.5 M (+9.55 %) |
Nov 15 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 9.91 | 10,000 | 99,100 | 42,985 | 33 K to 43 K (+30.32 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.47 | 215,133 | 2,037,847 | 1,369,273 | 1.2 M to 1.4 M (+18.64 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.75 | 215,133 | 2,097,934 | 1,154,140 | 939 K to 1.2 M (+22.91 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.74 | 145,680 | 1,418,384 | 939,007 | 793.3 K to 939 K (+18.36 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | P | 9.48 | 2,000 | 18,962 | 50,597 | 48.6 K to 50.6 K (+4.12 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.64 | 400 | 5,054 | 32,985 | 32.6 K to 33 K (+1.23 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.62 | 300 | 3,787 | 32,585 | 32.3 K to 32.6 K (+0.93 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.62 | 300 | 3,785 | 32,285 | 32 K to 32.3 K (+0.94 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.62 | 600 | 7,570 | 31,985 | 31.4 K to 32 K (+1.91 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.65 | 300 | 3,794 | 31,385 | 31.1 K to 31.4 K (+0.97 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.58 | 300 | 3,773 | 31,085 | 30.8 K to 31.1 K (+0.97 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.54 | 306 | 3,836 | 30,785 | 30.5 K to 30.8 K (+1.00 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.52 | 1,200 | 15,023 | 30,479 | 29.3 K to 30.5 K (+4.10 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.52 | 100 | 1,252 | 29,279 | 29.2 K to 29.3 K (+0.34 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.52 | 400 | 5,006 | 29,179 | 28.8 K to 29.2 K (+1.39 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.51 | 194 | 2,427 | 28,779 | 28.6 K to 28.8 K (+0.68 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.57 | 149 | 1,872 | 28,585 | 28.4 K to 28.6 K (+0.52 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.58 | 1,200 | 15,092 | 28,436 | 27.2 K to 28.4 K (+4.41 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.55 | 300 | 3,765 | 27,236 | 26.9 K to 27.2 K (+1.11 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.52 | 600 | 7,510 | 26,936 | 26.3 K to 26.9 K (+2.28 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.57 | 2,000 | 25,140 | 26,336 | 24.3 K to 26.3 K (+8.22 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.56 | 1,951 | 24,505 | 24,336 | 22.4 K to 24.3 K (+8.72 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.55 | 2,400 | 30,120 | 22,385 | 20 K to 22.4 K (+12.01 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.54 | 400 | 5,014 | 19,985 | 19.6 K to 20 K (+2.04 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.53 | 4,253 | 53,290 | 19,585 | 15.3 K to 19.6 K (+27.74 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.54 | 3,247 | 40,706 | 15,332 | 12.1 K to 15.3 K (+26.87 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.54 | 5,200 | 65,208 | 12,085 | 6.9 K to 12.1 K (+75.53 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.52 | 3,300 | 41,316 | 6,885 | 3.6 K to 6.9 K (+92.05 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.49 | 300 | 3,746 | 3,585 | 3.3 K to 3.6 K (+9.13 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | P | 12.49 | 300 | 3,746 | 3,285 | 3 K to 3.3 K (+10.05 %) |
Sep 18 2017 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Buy | P | 12.50 | 1,000 | 12,500 | 25,623 | 24.6 K to 25.6 K (+4.06 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | Swain Judith L | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | SOBECKI CHRISTOPHER J | Director | Grant | A | 0.00 | 1,281 | 0 | 10,480 | 9.2 K to 10.5 K (+13.93 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | Palantoni Frank | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | NIES ALAN S | Director | Grant | A | 0.00 | 1,281 | 0 | 11,052 | 9.8 K to 11.1 K (+13.11 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | LEFKOWITZ ROBERT J MD | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | DEBBANE RAYMOND | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | BARKER SAM L | Director | Grant | A | 0.00 | 1,281 | 0 | 24,623 | 23.3 K to 24.6 K (+5.49 %) |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Option Exercise | A | 15.61 | 2,857 | 44,598 | 2,857 | |
May 01 2017 | LEXG | LEXICON PHARMACEUT ... | Amouyal Philippe | Director | Grant | A | 0.00 | 1,281 | 0 | 10,338 | 9.1 K to 10.3 K (+14.14 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,075 | 0 | 6,225 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 2,668 | 0 | 5,336 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 1,339 | 0 | 1,340 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 857 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 16.45 | 2,790 | 45,896 | 20,095 | 22.9 K to 20.1 K (-12.19 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,075 | 0 | 22,885 | 20.8 K to 22.9 K (+9.97 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 2,668 | 0 | 20,810 | 18.1 K to 20.8 K (+14.71 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 1,339 | 0 | 18,142 | 16.8 K to 18.1 K (+7.97 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 857 | 0 | 16,803 | 15.9 K to 16.8 K (+5.37 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 4,495 | 0 | 13,485 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 5,807 | 0 | 11,614 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,928 | 0 | 2,929 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,429 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 16.45 | 6,455 | 106,185 | 48,597 | 55.1 K to 48.6 K (-11.73 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 4,495 | 0 | 55,052 | 50.6 K to 55.1 K (+8.89 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 5,807 | 0 | 50,557 | 44.8 K to 50.6 K (+12.98 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,928 | 0 | 44,750 | 41.8 K to 44.8 K (+7.00 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,429 | 0 | 41,822 | 39.4 K to 41.8 K (+6.17 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Option Exercise | M | 0.00 | 2,352 | 0 | 7,058 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Payment of Exercise | F | 16.45 | 1,093 | 17,980 | 1,259 | 2.4 K to 1.3 K (-46.47 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Santini Alexander A | EVP and CCO | Buy | M | 0.00 | 2,352 | 0 | 2,352 | 0 to 2.4 K |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 4,085 | 0 | 12,255 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 5,271 | 0 | 10,543 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,678 | 0 | 2,679 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Option Exercise | M | 0.00 | 2,357 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Payment of Exercise | F | 16.45 | 5,361 | 88,188 | 44,230 | 49.6 K to 44.2 K (-10.81 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 4,085 | 0 | 49,591 | 45.5 K to 49.6 K (+8.98 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 5,271 | 0 | 45,506 | 40.2 K to 45.5 K (+13.10 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,678 | 0 | 40,235 | 37.6 K to 40.2 K (+7.13 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, CMC and Supply ... | Buy | M | 0.00 | 2,357 | 0 | 37,557 | 35.2 K to 37.6 K (+6.70 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,227 | 0 | 12,683 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 4,550 | 0 | 9,100 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,822 | 0 | 2,821 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Payment of Exercise | F | 16.45 | 5,252 | 86,395 | 24,613 | 29.9 K to 24.6 K (-17.59 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,227 | 0 | 29,865 | 25.6 K to 29.9 K (+16.49 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 4,550 | 0 | 25,638 | 21.1 K to 25.6 K (+21.58 %) |
Mar 01 2017 | LEXG | LEXICON PHARMACEUT ... | Lapuerta Pablo | EVP and CMO | Buy | M | 0.00 | 2,822 | 0 | 21,088 | 18.3 K to 21.1 K (+15.45 %) |